AVITA Medical, Inc.
RCEL
$3.87
$0.205.45%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.92M | -13.86M | -11.59M | -16.21M | -15.39M |
| Total Depreciation and Amortization | 552.00K | 521.00K | 409.00K | 310.00K | 204.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 928.00K | 2.79M | 3.85M | 6.32M | 2.46M |
| Change in Net Operating Assets | -1.79M | 241.00K | -746.00K | 2.36M | -51.00K |
| Cash from Operations | -10.23M | -10.31M | -8.08M | -7.21M | -12.78M |
| Capital Expenditure | -524.00K | -221.00K | -1.61M | -3.76M | -2.65M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.54M | 10.99M | 4.08M | 11.15M | 15.08M |
| Cash from Investing | 7.02M | 10.77M | 2.47M | 7.39M | 12.43M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 559.00K | 363.00K | 1.02M | 1.01M | 849.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 559.00K | 363.00K | 1.02M | 1.01M | 849.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.65M | 820.00K | -4.59M | 1.19M | 501.00K |